FealtySign in

IDEX CORP /DE/

(IEX)

CIK 832101 · SEC filings only

Not gradedDividend record
shown as history
company entity
17 dividend record entries

Dividend record — shown as history, not graded

A declared dividend is a reported fact, not a promise we grade. Here's the record — raises, holds, and cuts — each linked to its source filing.

Dividend record

17 declarations · 0 raised · 0 held · 0 cut

  1. NOTED$1.4600/shperiod ended 2026-06-30Filing ↗
  2. NOTED$0.7100/shperiod ended 2025-09-30Filing ↗
  3. NOTED$1.4200/shperiod ended 2025-06-30Filing ↗
  4. NOTED$0.6900/shperiod ended 2024-09-30Filing ↗
  5. NOTED$1.3800/shperiod ended 2024-06-30Filing ↗
  6. NOTED$0.6400/shperiod ended 2023-09-30Filing ↗
  7. NOTED$1.2800/shperiod ended 2023-06-30Filing ↗
  8. NOTED$0.6000/shperiod ended 2022-09-30Filing ↗
  9. NOTED$1.2000/shperiod ended 2022-06-30Filing ↗
  10. NOTED$0.5400/shperiod ended 2021-09-30Filing ↗
  11. NOTED$1.0800/shperiod ended 2021-06-30Filing ↗
  12. NOTED$0.5000/shperiod ended 2020-09-30Filing ↗
Descriptive dividend record — every entry links to its source filing. Not graded (a declared dividend is a reported fact, not a promise). Full methodology →
Not yet gradedBuyback record
harness minimum not met
company entity
0 resolved promises

Not enough resolved promises to grade

0 of the 4 resolved buyback promises needed to publish a reliability grade. Here's what we're tracking — we never show a grade we can't back with receipts.

Pro

buyback history

Free scorecards show the 12 most recent resolved buyback promises. See the complete multi-year record with Pro.

See Pro →

Open promises (1)

Open · buyback authorization

Increased share repurchase authorization to $1 billion

resolves in ~414 days$1.00Breceipt →
0 resolved buyback promises · resolver resolver-v3 · score score-v1. Every verdict links to its source filing. Full methodology →
B−Guidance record
grade
company entity
37 resolved promises

Resolved promises

Pro

Full say-do history

Free scorecards show the 12 most recent resolved guidance promises. See the complete multi-year record with Pro.

See Pro →

Guidance shown, not graded (40)

These are non-GAAP forecasts. There is no comparable GAAP figure in SEC XBRL to check them against, so we show what was said — with its source filing — but never score it.

  1. eps guidance fy · Jul 29, 2026
    Full year adjusted diluted EPS of $8.70 to $8.85
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  2. eps guidance q · Jul 29, 2026
    Third quarter 2026 adjusted diluted EPS of $2.20 to $2.25
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  3. eps guidance fy · Apr 29, 2026
    Full year adjusted diluted EPS of $8.35 to $8.55
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  4. eps guidance q · Apr 29, 2026
    Second quarter 2026 adjusted diluted EPS of $2.07 to $2.12
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  5. eps guidance fy · Feb 4, 2026
    Full year adjusted diluted EPS of $8.15 to $8.35
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  6. eps guidance q · Feb 4, 2026
    First quarter 2026 adjusted diluted EPS of $1.73 to $1.78
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  7. eps guidance fy · Oct 29, 2025
    Adjusted diluted EPS of $7.86 - $7.91
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  8. eps guidance fy · Jul 30, 2025
    In 2025, the Company now expects to generate GAAP diluted EPS of $6.30 - $6.44
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  9. eps guidance q · Jul 30, 2025
    In the third quarter 2025, the Company expects to generate GAAP diluted EPS of $1.54 - $1.61
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  10. eps guidance fy · Feb 4, 2025
    adjusted diluted EPS of $8.10 to $8.45
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  11. eps guidance q · Feb 4, 2025
    adjusted diluted EPS of $1.60 to $1.65
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  12. eps guidance q · Oct 30, 2024
    Estimated adjusted diluted EPS attributable to IDEX $2.01 - $2.06
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  13. eps guidance fy · Oct 30, 2024
    Full year GAAP diluted EPS of $6.65 - $6.70
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  14. eps guidance q · Oct 30, 2024
    Estimated diluted EPS attributable to IDEX $1.64 - $1.69
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  15. eps guidance fy · Oct 30, 2024
    Adjusted diluted EPS of $7.85 - $7.90
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  16. eps guidance q · Feb 7, 2024
    Earnings per Share Adjusted* $1.70 - $1.75
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  17. eps guidance q · Oct 26, 2023
    adjusted diluted EPS of $1.74 - $1.79
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  18. eps guidance fy · Oct 26, 2023
    adjusted diluted EPS of $8.13 - $8.18
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  19. eps guidance q · Apr 27, 2023
    adjusted EPS of $2.10 to $2.13
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  20. eps guidance fy · Apr 27, 2023
    adjusted EPS of $8.25 to $8.55
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  21. eps guidance fy · Feb 1, 2023
    $8.50 - $8.80
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  22. eps guidance q · Feb 1, 2023
    Adjusted* $1.98 - 2.03
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  23. eps guidance q · Oct 26, 2022
    fourth quarter 2022 reported EPS attributable to IDEX of $1.75 to $1.80
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  24. eps guidance fy · Oct 26, 2022
    The Company expects full year 2022 reported EPS attributable to IDEX of $7.75 to $7.80
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  25. eps guidance q · Apr 27, 2022
    Estimated adjusted EPS attributable to IDEX $1.85 - $1.90
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  26. eps guidance q · Apr 27, 2022
    second quarter 2022 reported EPS attributable to IDEX of $1.69 to $1.74
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  27. eps guidance fy · Apr 27, 2022
    adjusted EPS attributable to IDEX of $7.50 to $7.63
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  28. eps guidance fy · Apr 27, 2022
    The Company expects full year 2022 reported EPS attributable to IDEX of $6.87 to $7.00
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  29. eps guidance q · Oct 27, 2021
    EPS in the range of $1.55 to $1.58
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  30. eps guidance fy · Oct 27, 2021
    narrowing our adjusted EPS range to $6.30 to $6.33
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  31. revenue guidance q · Jul 28, 2021
    a 14 to 16 percent organic sales increase in the third quarter
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  32. revenue guidance fy · Jul 28, 2021
    we are now projecting 11 to 12 percent organic sales growth for the full year 2021
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  33. eps guidance fy · Jul 28, 2021
    Full year 2021 adjusted EPS is now projected to be $6.26 to $6.36
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  34. eps guidance q · Jul 28, 2021
    third quarter adjusted EPS of $1.57 to $1.61
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  35. eps guidance fy · Apr 28, 2021
    raising our full year adjusted EPS guidance to $6.05 to $6.20
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  36. eps guidance q · Apr 28, 2021
    second quarter adjusted EPS of $1.60 to $1.63
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  37. eps guidance q · Feb 4, 2021
    with first quarter EPS of $1.38 to $1.42
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  38. eps guidance fy · Feb 4, 2021
    Full year 2021 EPS is projected to be $5.65 to $5.95
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  39. eps guidance fy · Jan 30, 2019
    Full year 2019 EPS is expected to be in the range of $5.60 to $5.80
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  40. eps guidance q · Jan 30, 2019
    first quarter EPS in the range of $1.35 to $1.38
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗

Open promises (5) · 17 superseded

Open · revenue guidance q

we expect organic sales growth of 9 to 10 percent

no set deadlinereceipt →
Open · revenue guidance fy

maintaining our projection of 11 to 12 percent organic sales growth

no set deadlinereceipt →
Open · eps guidance q

GAAP diluted EPS of $1.50 - $1.55

unresolved — no outcome on filereceipt →
Open · revenue guidance q

Third quarter 2026 organic sales projected to increase 5% to 7% from the prior year period

resolves in ~111 daysreceipt →
Open · revenue guidance fy

Full year organic sales projected to increase 5% to 6% over the prior year

resolves in ~202 daysreceipt →
Superseded · eps guidance fy

We expect full year 2022 GAAP EPS of $6.70 to $7.00

revised by a later guidancereceipt →
Superseded · eps guidance fy

GAAP EPS of $7.30 to $7.60

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Full year 2022 organic sales growth is projected to be 6 to 8 percent

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Full year organic sales growth is projected to be 0% to 2% over the prior year

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Full year 2023 organic sales are projected to decline 1 to 2 percent over the prior year

revised by a later guidancereceipt →
Superseded · revenue guidance fy

FY 2023 Guidance Range* $3,345 - $3,461

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Organic sales growth is projected to be 5 to 8 percent for 2022

revised by a later guidancereceipt →
Superseded · revenue guidance fy

FY 2024 Guidance Range* $3,320 - $3,386

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Full year 2023 organic sales growth is projected to be 0 to 3 percent over the prior year period

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Full year organic sales are projected to increase 1% to 3% over the prior year

revised by a later guidancereceipt →
Superseded · eps guidance fy

Full year GAAP diluted EPS of $7.13 - $7.43

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Full year organic sales projected to increase 1% to 2% over the prior year

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Full year organic sales projected to increase 3% to 4% over the prior year

revised by a later guidancereceipt →
Superseded · revenue guidance fy

Full year 2022 organic sales growth is projected to be approximately 10 percent

revised by a later guidance$10.0000receipt →
Superseded · eps guidance fy

Full year GAAP diluted EPS of $6.56 to $6.96

revised by a later guidancereceipt →
Superseded · eps guidance fy

GAAP EPS of $6.80 - $6.90

revised by a later guidancereceipt →
Superseded · eps guidance fy

the Company expects to generate GAAP diluted EPS of $6.56 - $6.95

revised by a later guidancereceipt →

Credibility timeline

BEAT · Feb 20, 2025MISSED · Feb 20, 2025BEAT · Feb 20, 2025BEAT · May 1, 2025BEAT · May 1, 2025BEAT · Jul 30, 2025BEAT · Jul 30, 2025BEAT · Oct 29, 2025BEAT · Feb 19, 2026BEAT · Feb 19, 2026KEPT · Apr 29, 2026BEAT · Jul 29, 2026
20252026
Timeline as a list
  • Feb 20, 2025BEATChange in organic net sales 3  % 4  %
  • Feb 20, 2025MISSEDFull year GAAP diluted EPS of $6.85 - $6.95
  • Feb 20, 2025BEATFull year organic sales growth is projected to decline 1% to 2% versus the prior year
  • May 1, 2025BEATFirst quarter GAAP diluted EPS of $1.18 to $1.24
  • May 1, 2025BEATFirst quarter 2025 organic sales are projected to decrease 3% to 4% from the prior year period
  • Jul 30, 2025BEATexpected second quarter 2025 organic sales growth of 0% to 2%
  • Jul 30, 2025BEATthe Company expects to generate GAAP diluted EPS of $1.60 - $1.72
  • Oct 29, 2025BEATexpected third quarter 2025 organic sales growth of 2% to 3%
  • Feb 19, 2026BEATGAAP diluted EPS of $6.35 - $6.40
  • Feb 19, 2026BEATexpected full year organic sales growth of 1% to 3%
  • Apr 29, 2026KEPTFirst quarter 2026 organic sales projected to increase approximately 1% from the prior year period
  • Jul 29, 2026BEATSecond quarter 2026 organic sales projected to increase 3% to 4% from the prior year period
37 resolved guidance promises · 40dropped (couldn't be resolved on a consistent basis) · resolver resolver-v3 · score score-v1. Every verdict links to its source filing. Full methodology →